DSpace at RU >

Browsing by Author Reiss, P.

Full Text	Issue Date	Title	Author(s)
	2010	High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.	Worm, S.W.; Friis-Moller, N.; Bruyand, M., et al
	2010	Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals.	Sighem, A.I. van; Gras, L.A.; Reiss, P., et al
	2011	The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentration	Bierman, W.F.; Vonderen, M.G. van; Veldkamp, A.I., et al
	2004	Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients.	Valk, M. van der; Allick, G.; Weverling, G.J., et al
	2005	Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.	Porte, C.J.L. la; Verweij-van Wissen, C.P.W.G.M.; Ewijk, N. van, et al
	2007	Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.	Lee, M. van der; Sankatsing, R.; Schippers, E., et al
	2010	Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.	Friis-Moller, N.; Thiebaut, R.; Reiss, P., et al
	2007	Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen.	Autar, R.S.; Boyd, M.A.; Wit, F.W., et al
	2007	Risico's behandeling hyperlipidemie bij hiv. Interacties tussen statines en antiretrovirale middelen.	Burger, D.M.; Lee, M.J. van der; Reiss, P.
	2009	Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.	Kesselring, A.M.; Wit, F.W.; Sabin, C.A., et al
	1995	Schimmelinfecties bij patienten met een gestoorde afweer.	Wout, J.W. van 't; Kullberg, B.J.; Meis, J.F.G.M., et al
	1995	Schimmelinfecties bij patiënten met een gestoorde afweer	Wout, J.W. van 't; Kullberg, B.J.; Meis, J.F.G.M., et al
	2007	Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen.	Lowe, S.H.; Leeuwen, E. van; Droste, J.A.H., et al
	2006	Sympathetic nervous system function in HIV-associated adipose redistribution syndrome.	Gurp, P.J.M. van; Tack, C.J.J.; Valk, M. van der, et al
	2006	The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.	Boyd, M.A.; Siangphoe, U.; Ruxrungtham, K., et al
	2009	Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.	Mocroft, A.; Sterne, J.A.; Egger, M., et al